author-photo

Elizabeth A. Raetz

New York University
University of Utah
Primary Children's Hospital

327

Papers

10095

Citations

Citation Trend

Filter By

Papers (327) Sort By

Journal Conference Others

Intensification of Chemotherapy Using a Modified BFM Backbone for Children, Adolescents and Young Adults with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Identifies Highly Chemorefractory Patients Who Benefit from Allogeneic Hematopoietic Stem Cell Transplantation

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic Impact of CNS-2 status in T-ALL: A report from the Children’s Oncology Group.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (3)
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL: Safety Phase Results from Children’s Oncology Group Protocol AALL1732

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia.

2021 Journal of Clinical Investigation
Show All
- Source
- Cite
- Save
Citations (1)
Blinatumomab Associated Seizure Risk in Patients with Down Syndrome and B-Lymphoblastic Leukemia: An Interim Report from Children’s Oncology Group (COG) Study AALL1731

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Non-Classical Monocyte Abundance Is an Independent Adverse Risk Factor for Relapse in Pediatric B-ALL

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.

2021 JAMA
Show All
- Source
- Cite
- Save
Citations (24)
Targeted gene expression classifier identifies pediatric T-cell acute lymphoblastic leukemia (T-ALL) patients at high risk for end induction minimal residual disease positivity.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (2)